Trial of Modafinil to Improve Neurocognitive Deficits in Children Treated for a Primary Brain Tumor

Clinical Trial

Offered by: Nemours Children's
Locations: Delaware Valley and Jacksonville in Florida

Trial Name

Phase II Placebo-Controlled Trial of Modafinil to Improve Neurocognitive Deficits in Children Treated for a Primary Brain Tumor

What is the trial about?

Compares the effects (good and/or bad) of a medicine called modafinil to a placebo (no active medicine).

Who can participate?

Patients who have been treated for a primary brain tumor with surgery, chemotherapy and/or radiation therapy.

What is involved?

  • The study will last a maximum of 10 weeks. 
  • Your child will take modafinil or placebo daily for 6 weeks. Then he/she will repeat tests that were given before starting study medicine.
  • 30 days later the study staff will see how he/she is doing.

Contact Nemours Children's Clinical Trials

Trial Name: Phase II Placebo-Controlled Trial of Modafinil to Improve Neurocognitive Deficits in Children Treated for a Primary Brain Tumor
IRB#: ACCL0922

Is a Clinical Trial Right for Your Child?

Learn more about clinical trials and get answers to questions you might have.

Two researchers in a lab wearing coats and gloves, one looks into a microscope.